Metraipolis › archive › dc_5ceeea96d5c8
CAR-T cell therapy in TP53-mutated CNS lymphoma: overcoming a high-risk genetic barrier — Europe PMC PMID:41608436
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41608436
- DOI
- 10.3389/fmed.2025.1731589
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T20:35:52.617Z
- SHA-256 of the archived text
0dd2229744ae7a5b6fa939c759029146556f9c71cffb7150a1dbfd4d94bc182a- Stable URL of this page
https://metraipolis.com/documento/dc_5ceeea96d5c8
How to cite
CAR-T cell therapy in TP53-mutated CNS lymphoma: overcoming a high-risk genetic barrier — Europe PMC PMID:41608436 — Europe PMC (en), https://europepmc.org/article/MED/41608436 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ceeea96d5c8 (Metraipolis archive dc_5ceeea96d5c8, sha256 0dd2229744ae7a5b6fa939c759029146556f9c71cffb7150a1dbfd4d94bc182a)
BibTeX
@misc{dc5ceeea96d5c8,
title = {CAR-T cell therapy in TP53-mutated CNS lymphoma: overcoming a high-risk genetic barrier — Europe PMC PMID:41608436},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41608436},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ceeea96d5c8; sha256 0dd2229744ae7a5b6fa939c759029146556f9c71cffb7150a1dbfd4d94bc182a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41608436. Agents can read the archived copy with the MCP tool read_document.